Nanobiotix (NBTX) Liabilities and Shareholders Equity: 2020-2024

Historic Liabilities and Shareholders Equity for Nanobiotix (NBTX) over the last 4 years, with Dec 2024 value amounting to $72.0 million.

  • Nanobiotix's Liabilities and Shareholders Equity fell 45.22% to $51.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $317.5 million, marking a year-over-year decrease of 2.11%. This contributed to the annual value of $72.0 million for FY2024, which is 29.07% down from last year.
  • Per Nanobiotix's latest filing, its Liabilities and Shareholders Equity stood at $72.0 million for FY2024, which was down 29.07% from $101.6 million recorded in FY2023.
  • Nanobiotix's 5-year Liabilities and Shareholders Equity high stood at $153.0 million for FY2020, and its period low was $72.0 million during FY2024.
  • Its 2-year average for Liabilities and Shareholders Equity is $86.8 million, with a median of $86.8 million in 2023.
  • Data for Nanobiotix's Liabilities and Shareholders Equity shows a maximum YoY dropped of 29.07% (in 2024) over the last 5 years.
  • Over the past 4 years, Nanobiotix's Liabilities and Shareholders Equity (Yearly) stood at $153.0 million in 2020, then declined by 21.30% to $120.4 million in 2021, then reached $101.6 million in 2023, then declined by 29.07% to $72.0 million in 2024.